Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Veterans helping veterans: peer coaches aim to clarify prostate cancer screening choices

NCT ID NCT06549036

Knowledge-focused Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 20, 2026 · Updated 3 times

Summary

This study tests whether trained veteran peer navigators can help men aged 40-69 make informed choices about PSA screening for prostate cancer. Participants will receive a decision coaching session to understand the pros and cons of screening. The goal is to see if this approach reduces confusion and leads to decisions that match each veteran's values.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Veteran Peer Decision Coaching Session for PSA Screening
What this could lead to
If successful, this could show that peer coaching helps veterans make better-informed decisions about PSA screening, balancing benefits and risks.
What could go wrong
This is a small, early-stage behavioral study (228 participants) focused on decision-making, not on curing or treating cancer. Results may not apply to other groups or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 228 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 69 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Veteran patient participants: * Veteran * Male * Attending VANYHHS-Manhattan for routine primary care appointment Providers: * Primary care provider at VA New York Harbor Healthcare System (VANYHHS) * Caring for patients that fit inclusion criteria Exclusion Criteria: Veteran Patients: * Patients seen within 9 months of other PSA tests * Patients seen within 180 days after primary diagnosis of urinary obstruction, prostatitis, hematuria, other disorder of prostate, unexplained weight loss, or lumbar back pain * Patients with a prior diagnosis of prostate cancer (ICD-10-CM C61) * Patients visiting their provider for any indication other than a well-visit appointment Providers: \- Providers who do not treat adult male patients (e.g. OB/Gyns, pediatricians)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prostate cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prostate cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • VA NY Harbor Healthcare System, New York, NY

    New York, New York, 10010-5011, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.